These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37767312)

  • 1. Immunomodulation with IL-7 and IL-15 in HIV-1 infection.
    Gunst JD; Goonetilleke N; Rasmussen TA; Søgaard OS
    J Virus Erad; 2023 Sep; 9(3):100347. PubMed ID: 37767312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
    Macedo AB; Levinger C; Nguyen BN; Richard J; Gupta M; Cruz CRY; Finzi A; Chiappinelli KB; Crandall KA; Bosque A
    J Virol; 2022 Aug; 96(15):e0037222. PubMed ID: 35867565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
    Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
    mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production.
    Ziegler A; Olzhausen J; Hamza E; Stojiljkovic A; Stoffel MH; Garbani M; Rhyner C; Marti E
    Vet Immunol Immunopathol; 2022 Jan; 243():110351. PubMed ID: 34800874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.
    Jost S; Tomezsko PJ; Rands K; Toth I; Lichterfeld M; Gandhi RT; Altfeld M
    J Virol; 2014 Aug; 88(15):8349-54. PubMed ID: 24829350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
    Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
    Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation.
    Pahwa R; McCloskey TW; Aroniadis OC; Strbo N; Krishnan S; Pahwa S
    J Infect Dis; 2006 Mar; 193(6):879-87. PubMed ID: 16479523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8
    Kwaa AKR; Talana CAG; Blankson JN
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
    Alpdogan O; Eng JM; Muriglan SJ; Willis LM; Hubbard VM; Tjoe KH; Terwey TH; Kochman A; van den Brink MR
    Blood; 2005 Jan; 105(2):865-73. PubMed ID: 15280205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
    Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR
    J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells mediate clearance of CD8
    Nicolai CJ; Wolf N; Chang IC; Kirn G; Marcus A; Ndubaku CO; McWhirter SM; Raulet DH
    Sci Immunol; 2020 Mar; 5(45):. PubMed ID: 32198222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
    Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
    J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells.
    Zecher D; Li Q; Oberbarnscheidt MH; Demetris AJ; Shlomchik WD; Rothstein DM; Lakkis FG
    J Immunol; 2010 Jun; 184(12):6649-57. PubMed ID: 20483732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
    Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE
    J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.
    Wren L; Parsons MS; Isitman G; Center RJ; Kelleher AD; Stratov I; Bernard NF; Kent SJ
    PLoS One; 2012; 7(6):e38580. PubMed ID: 22701674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.